The effects of MyD88 deficiency on exploratory activity, anxiety, motor coordination, and spatial learning in C57BL/6 and APPswe/PS1dE9 mice

Behavioural Brain Research

Volumn 227, Issue 1, 2012, Pages 36-42

  Lim, Jeong Eun ^a   Song, Min ^a   Jin, Jingji ^a   Kou, Jinghong ^a   Pattanayak, Abhinandan ^a   Lalonde, Robert ^b   Fukuchi, Ken ichiro ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

Alzheimer's disease; Anxiety; Cognitive function; Memory; MyD88; Toll like receptors

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; LEARNING; MALE; MAZE TEST; METABOLIC DISORDER; MORRIS WATER MAZE TEST; MOTOR COORDINATION; MOUSE; MYELOID DIFFERENTIATION FACTOR 88 DEFICIENCY; NONHUMAN; PRIORITY JOURNAL; SPATIAL LEARNING; TRANSGENE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANXIETY; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HUMANS; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MYELOID DIFFERENTIATION FACTOR 88; PRESENILIN-1; PSYCHOMOTOR PERFORMANCE; SPACE PERCEPTION; TIME FACTORS;

EID: 81155128085     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.10.027     Document Type: Article

References (49)

1. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384.
2. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
3. Keogh B., Parker A.E. Toll-like receptors as targets for immune disorders. Trends Pharmacol Sci 2011, 32:435-442.
4. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
5. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011, 25:181-213.
6. Okun E., Griffioen K., Barak B., Roberts N.J., Castro K., Pita M.A., et al. Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc Natl Acad Sci USA 2010, 107:15625-15630.
7. Hanke M.L., Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) 2011, 121:367-387.
8. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA 2003, 100:13632-13637.
9. Bonde S., Ekdahl C.T., Lindvall O. Long-term neuronal replacement in adult rat hippocampus after status epilepticus despite chronic inflammation. Eur J Neurosci 2006, 23:965-974.
10. Wu C.W., Chen Y.C., Yu L., Chen H.I., Jen C.J., Huang A.M., et al. Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory. J Neurochem 2007, 103:2471-2481.
11. Butovsky O., Ziv Y., Schwartz A., Landa G., Talpalar A.E., Pluchino S., et al. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 2006, 31:149-160.
12. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 2007, 9:1081-1088.
13. Marin-Burgin A., Schinder A.F. Requirement of adult-born neurons for hippocampus-dependent learning. Behav Brain Res 2011, 10.1016/j.bbr.2011.07.001.
14. Eisch A.J., Cameron H.A., Encinas J.M., Meltzer L.A., Ming G.L., Overstreet-Wadiche L.S. Adult neurogenesis, mental health, and mental illness: hope or hype?. J Neurosci 2008, 28:11785-11791.
15. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21:383-421.
16. Liu Y., Walter S., Stagi M., Cherny D., Letiembre M., Schulz-Schaeffer W., et al. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain 2005, 128:1778-1789.
17. Stewart C.R., Stuart L.M., Wilkinson K., van Gils J.M., Deng J., Halle A., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010, 11:155-161.
18. Reed-Geaghan E.G., Savage J.C., Hise A.G., Landreth G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J Neurosci 2009, 29:11982-11992.
19. DiCarlo G., Wilcock D., Henderson D., Gordon M., Morgan D. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiol Aging 2001, 22:1007-1012.
20. Herber D.L., Roth L.M., Wilson D., Wilson N., Mason J.E., Morgan D., et al. Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. Exp Neurol 2004, 190:245-253.
21. Malm T.M., Koistinaho M., Parepalo M., Vatanen T., Ooka A., Karlsson S., et al. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 2005, 18:134-142.
22. Quinn J., Montine T., Morrow J., Woodward W.R., Kulhanek D., Eckenstein F. Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease. J Neuroimmunol 2003, 137:32-41.
23. Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., Fukuchi K.I. Role of toll-like receptor signalling in A{beta} uptake and clearance. Brain 2006, 129:3006-3019.
24. Lee J.W., Lee Y.K., Yuk D.Y., Choi D.Y., Ban S.B., Oh K.W., et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation 2008, 5:37.
25. Richard K.L., Filali M., Prefontaine P., Rivest S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 2008, 28:5784-5793.
26. Scholtzova H., Kascsak R.J., Bates K.A., Boutajangout A., Kerr D.J., Meeker H.C., et al. Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. J Neurosci 2009, 29:1846-1854.
27. Doi Y., Mizuno T., Maki Y., Jin S., Mizoguchi H., Ikeyama M., et al. Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease. Am J Pathol 2009, 175:2121-2132.
28. Lim J., Kou J., Song M., Pattanyak A., Jin J., Lalonde R., et al. MyD88 deficiency ameliorates beta-amyloidosis in an animal model of Alzheimer's disease. Am J Pathol 2011, 179:1095-1103.
29. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
30. Jankowsky J.L., Fadale D.J., Anderson J., Xu G.M., Gonzales V., Jenkins N.A., et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004, 13:159-170.
31. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998, 9:143-150.
32. Lalonde R., Kim H.D., Fukuchi K. Exploratory activity, anxiety, and motor coordination in bigenic APPswe+PS1/DeltaE9 mice. Neurosci Lett 2004, 369:156-161.
33. Lalonde R., Kim H.D., Maxwell J.A., Fukuchi K. Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques. Neurosci Lett 2005, 390:87-92.
34. Van Dam D., D'Hooge R., Staufenbiel M., Van Ginneken C., Van Meir F., De Deyn P.P. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci 2003, 17:388-396.
35. Lee K.W., Lee S.H., Kim H., Song J.S., Yang S.D., Paik S.G., et al. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. J Neurosci Res 2004, 76:572-580.
36. File S.E. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 2001, 125:151-157.
37. Anisman H., Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 1999, 461:199-233.
38. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1beta, -2,-6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 1998, 84:923-933.
39. Cragnolini A.B., Schioth H.B., Scimonelli T.N. Anxiety-like behavior induced by IL-1beta is modulated by alpha-MSH through central melanocortin-4 receptors. Peptides 2006, 27:1451-1456.
40. Balaram P., Kien P.K., Ismail A. Toll-like receptors and cytokines in immune responses to persistent mycobacterial and Salmonella infections. Int J Med Microbiol 2009, 299:177-185.
41. Lacosta S., Merali Z., Anisman H. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects. Brain Res 1999, 818:291-303.
42. Swiergiel A.H., Dunn A.J. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 2007, 86:651-659.
43. Koo J.W., Duman R.S. Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett 2009, 456:39-43.
44. Bluthe R.M., Castanon N., Pousset F., Bristow A., Ball C., Lestage J., et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 1999, 24:301-311.
45. Kempermann G., Gage F.H. Genetic determinants of adult hippocampal neurogenesis correlate with acquisition, but not probe trial performance, in the water maze task. Eur J Neurosci 2002, 16:129-136.
46. Choi S.H., Veeraraghavalu K., Lazarov O., Marler S., Ransohoff R.M., Ramirez J.M., et al. Non-cell-autonomous effects of presenilin 1 variants on enrichment-mediated hippocampal progenitor cell proliferation and differentiation. Neuron 2008, 59:568-580.
47. Veeraraghavalu K., Choi S.H., Zhang X., Sisodia S.S. Presenilin 1 mutants impair the self-renewal and differentiation of adult murine subventricular zone-neuronal progenitors via cell-autonomous mechanisms involving notch signaling. J Neurosci 2010, 30:6903-6915.
48. Hao W., Liu Y., Liu S., Walter S., Grimm M.O., Kiliaan A.J., et al. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology. Brain 2011, 134:278-292.
49. Frautschy S.A., Cole G.M. Why pleiotropic interventions are needed for Alzheimer's disease. Mol Neurobiol 2010, 41:392-409.